![logo](/logos/002038.SZ.webp)
Beijing SL Pharmaceutical Co., Ltd.
SZSE:002038.SZ
11.78 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Beijing SL Pharmaceutical Co., Ltd. |
Symbool | 002038.SZ |
Munteenheid | CNY |
Prijs | 11.69 |
Beurswaarde | 12,009,721,687 |
Dividendpercentage | 1.18% |
52-weken bereik | 8.13 - 16.09 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Mingbo Xu |
Website | https://www.slpharm.com.cn |
An error occurred while fetching data.
Over Beijing SL Pharmaceutical Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin;
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)